We were also helped by an allocation to the Consumer Discretionary sector where some of our positions did well on an idiosyncratic basis.
Amongst the main detractors was our exposure to the Healthcare sector where the market was concerned on the possible impact of a proposed legislation in the US on one of our investee companies.
On a regional basis, the Trust was positively benefited from its allocation to Taiwan and in particular to TSMC, which remains the largest exposure to the Trust.
The Trust also benefited from the exposure to South Korea. The Trust continues to be overweight Korea, which represents 20% of the Trust assets with exposure across several industries such as semiconductor, insurance holding companies, Internet, construction machinery, life sciences, etc.
In India, the Trust was impacted by the exposure to a fintech company which got impacted by regulatory action.
Our Latin America exposure suffered in the first quarter as Brazil faced headwinds on the policy front and companies continue to face a tough macro environment.
Interest rates have remained elevated, impacting the profitability of companies as well as curtailing the demand environment.
We continue to have a significant overweight to Brazil looking past this period.
Amongst the major additions to cement in the first quarter, we have added to Samsung Electronics in Korea, Tencent and Prosus in China, and have added new companies such as SK Hynix in Korea, Encore Clinicas in Brazil and Discovery in South Africa.
Amongst the major stocks we trimmed in the quarter were TSMC, which remains the largest holding, ICICI bank where we took some profits, and companies such as Samsung Life, LegoChem, LG Corp in Korea, and Brilliance Automotive in China, all of which had a significant run up.
We continue to focus on companies reflecting our philosophy of owning holdings in good quality businesses with long-term sustainable earnings power and at share prices which are at a discount to intrinsic worth.